期刊文献+

慢性肾衰竭患者血清KYN和KYNA测定临床应用初探 被引量:2

Clinical Application of Determination of Serum Kynurenic Acid and Kynurenine in Patients with Chronic Renal Failure
原文传递
导出
摘要 目的探讨慢性肾功能衰竭(CRF)中血清犬尿氨酸(KYN)和犬尿喹啉酸(KYNA)含量以及KYNA/KYN比值的临床意义。方法测定慢性肾衰(CRF)患者(n=76例)血清KYN、KYNA含量,探讨慢性肾衰患者不同阶段血清KYN和KYNA含量变化及其在鉴别诊断、治疗监测、机制研究等方面的临床意义。结果与正常对照组相比,CRF组血清KYN和KYNA含量显著升高(P<0.01);CRF组患者各阶段血清KYN和KYNA含量随病情发展升高(P<0.01)。CRF组血清KYN和KYNA含量与肾功能状态有一定相关性。结论通过对CRF患者血清KYN和KYNA含量的测定,结果表明CRF患者血清KYN和KYNA含量随病情发展发生变化,并与血清BUN和CR等肾功能指标相关。 Objective To explore the clinical significance of determination of serum KYN and KYNA in patients with chronic renal failure (CRF). Methods The concentrations of serum KYN and KYNA in CRF patients (n=76) were determined to explore the clinical significance of serum KYN and KYNA determined in different progresses of CRF. Results Compared with control group, the concentrations of serum KYN and KYNA in CRF group were significantly increased (P 〈 0.01). The concentrations of serum KYN and KYNA in different stages of CRF patients were increased with the development of CRF (P〈0.01). In CRF group, the concentrations of serum KYN and KYNA shewed positive correlation with renal function. Conclusions The results suggest that the concentrations of serum KYN and KYNA of CRF patients alter with the development of CRF, and are positively correlated with serum BUN and GR.
出处 《实用预防医学》 CAS 2010年第5期983-985,共3页 Practical Preventive Medicine
关键词 高效液相色谱法 犬尿氨酸 犬尿喹啉酸 慢性肾衰竭 High performance liquid chromatography Kynurenine Kynurenic acid Chronic renal failure
  • 相关文献

参考文献14

  • 1叶任高,陆再英.内科学[M].第6版.北京:人民卫生出版社,2006:787-788.
  • 2Rosenblum ND. The mesangial matrix in the normal and sclerotic glomerules[J]. Kidney Int, 1994, 45(Suppl 45) :873 - 877.
  • 3Kafami S, Border WA, Miller DE, et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells[J ]. J Clin Invest, 1994, 93:2431 - 2437.
  • 4Yoshida H, Kon V , Ichikawa I. Polymorphisrn s of the reninangiotensin systeln-genes in progressive renal diseases[J ]. Kidney Int, 1996, 50 : 732 - 744.
  • 5Yoshida H, Kuriyama S, A tsumi Y, et al. Angiotensin E converting enzyme- gene polymorphism in noninsulin dependent diabetes mellitus [J]. Kidney Int, 1995, 49: 657-664.
  • 6Rabelink TJ, Kaasjager KAH, Stroes ESG, et al. Endothelin in renal pathphysiology." from experimental to therapeutic application[J ]. Kidney Int, 1996, 50: 1827-1833.
  • 7Ungar A, Cristofari C, Torrini M, et al. Changes in renal autacoids in aged human hypertensives[J]. J Pysiol Pharrnaeol, 2000, 51: 619- 630.
  • 8Saito K, Fujigaki S, Heyes MP, et al. Mechanism of increases in L - kynurenine and quinolinic acid in renal insufficiency[J ]. Am J Physiol 9 Renal Physiol,2000, 279 (3) : 565 - 572.
  • 9Pawlak D, Tankiewic A, Buczko W. Kynurenine and its metabolites in the rat with experimental renal insufficieney[J ]. J Physiol Pharmacol, 2001,52(4) : 755 - 766.
  • 10Fukui, S Schwartz, R Rapoport, SI, et al.Blood brain transport of kynurenines: implications for brain synthesis and metabolism [J ]. J Neurcchem, 1991,56 : 2007 - 2017.

二级参考文献7

  • 1Kapoor V,Kapoor,Cbalmers J.Kynurenic acid,an endogenous glutamate antagonist,in SHR and WKY rats:possible role in central blood pressure regulation[J].Clin Exp Pharmacol Physiol,1994,21(11):891-896.
  • 2Chiarugi A,Carpenedo R,Teresa M,et al.Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase[ J ].Neurochem,1995,65(3):1176-1183.
  • 3Mizutani K,Sugimoto K,Okuda T,et al.Kynureninase is a novel candidate gene for hypertension in spontaneously hypertensive rats[J].Hyptens Res,2002,25 (1):135-140.
  • 4Shibata K.Fluorimetric micro-determination of kynurenic acid,an endogenous blocker of neurotoxicity,by high-performance liquid chromatography[ J ].Chromatogr,1988,430 (2):376-380.
  • 5Swartz KJ,Duing MJ,Freese A,et al.Cerebral synthesis and release of kynurenic acid:an endogenous antagonist of excitatory amino acid receptors[ J ].Neuroscience,1990,10 (9):2965-2973.
  • 6Kapoor V,Thuruthyil SJ,Human B.Reduced kynurenine aminotransferase-I activity in SHR rats may be due to lack of KAT-Ib activity[J].Neuroreport,1998,9 (7):1431-1434.
  • 7Yu P,Li Z,Zhang L,et al.Characterization of kynurenine aminotransferase Ⅲ,a novel member of a phylogenetically conserved KAT family[J].Gene,2006,365:111-118.

共引文献216

同被引文献23

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部